Discussion: Overcoming Resistance Dynamics in Tertiary Settings
The integration of dedicated antimicrobial stewardship programs within university hospitals illustrates the dual necessity of administrative leadership and clinical engagement in curbing drug resistance [4]. Institutional evidence confirms that structured quality improvement initiatives, incorporating tailored antibiotic policies and prospective audit mechanisms, systematically encourage the adoption of narrow-spectrum therapeutic agents over broad-spectrum alternatives [1]. Such interventions substantially reduce inappropriate empiric prescribing while preserving critical second-line therapies for high-risk infections. Nevertheless, the operationalization of these frameworks within tertiary teaching facilities frequently encounters friction regarding clinical autonomy and decision-making hierarchies [3]. Prescribers in academic medical centers often navigate competing clinical demands, specialized subspecialty protocols, and varied diagnostic support, which can attenuate adherence to centralized hospital formularies [3]. Addressing these systemic barriers necessitates moving beyond passive guideline dissemination toward active, multidisciplinary collaboration that engages clinical pharmacists, microbiologists, and infectious disease specialists [4]. Establishing continuous audit loops paired with non-punitive feedback fosters institutional cultures that prioritize diagnostic-guided therapy and systematic antibiotic de-escalation [1]. Consequently, sustainable antimicrobial containment in academic healthcare environments relies not merely on formulary restriction, but on institutionalizing cohesive governance structures that align departmental workflows with evidence-based prescribing standards.